Planned closure for Emergencies from 12pm onwards New entrance to the practice PLANNED CLOSURE FOR TRAINING: Wednesday 24th January from 12pm-6.30pm Update on our Pilot on Access 22/1/2024 Reduction in waiting times and improving access Merry Christmas and a Happy New Year Children in Need 2023 THE NHS APP AND ACCESS TO YOUR ONLINE RECORDS IMPORTANT UPDATE FOR OUR PATIENTS REGARDING COVID SECURE MEASURES 10/10/2023 Accurx online triage system
Edoxaban is currently the preferred DOAC to use for Non-valvular Atrial Fibrillation (NV-AF).
Edoxaban is the preferred anticoagulant locally. Using edoxaban instead of other anticoagulants will help your local NHS to treat more patients. This is because two patients can be treated with edoxaban in comparison to one patient treated with another anticoagulant.
Consider edoxaban, if clinically appropriate, as an alternative for existing NV-AF patients prescribed rivaroxaban, apixaban, dabigatran or warfarin
TWO patients can be treated with edoxaban in comparison to ONE patient with either apixaban, dabigatran or rivaroxaban.
Patient Information Leaflet & Alert Card
When switching patients to edoxaban, ensure they receive the patient information leaflet, alongside the manufacturer’s alert card and leaflet that they will receive with their edoxaban tablets pack.
Edoxaban is taken ONCE a day and can be taken with or without food, swallowing the whole tablet, preferably with water. Try to take your Edoxaban regularly at the same time each day, and continue to do so unless your doctor tells you to stop. If you have difficulty swallowing the tablet whole, talk to a doctor or pharmacist about other ways to take Edoxaban.
Instructions for switching
Add Read code (8B316) or SnoMed code (182838006) for medication changed.